The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular imaging technology can guide prostate cancer surgery. The project will evaluate the imaging technology’s ability to detect prostate cancer during surgery, with the aim of performing more accurate removal of cancerous tissue.

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/CT (positron emission tomography/computed tomography) in restaging and treatment response assessment of malignant disease. As cancer patients move through therapy, FDG PET/CT has proven an effective tool for assessing treatment response and updating the stage of malignancy. This AUC aims to improve utilization and guide providers across specialties in its use.

October 25, 2017 — ViewRay Inc. announced outcomes data presented during the recent 2017 Annual Meeting of the American ...

Philips recently announced the key findings of its research focused on the patient experience in diagnostic imaging procedures. Philips’ Patient Experience in Imaging Study surveyed 603 patients in the United States and Germany about their satisfaction, expectations, preferences and unmet needs with diagnostic imaging procedures in the past year. Patients identified trust in the referring doctor, communication, comfort, safety and getting the image right the first time as key priorities. The research provides insight into how patients perceive imaging procedures, what they value during the process, and what healthcare professionals can do to create a more patient-centered imaging experience.

Scientists have devised a portable, noninvasive direct approach to image infant brain activity in a clinical setting without relying on massive scanning machines. The method has been used to monitor seizures with higher resolution than what other technologies can currently achieve. Insight about infant brain activity from the new technology could potentially pave the way to therapeutic innovations for neurological disorders.

Mayo Clinic in Rochester, Minn., will have the first clinical 7-Tesla magnetic resonance imaging (MRI) scanner in North America that has been cleared by the U.S. Food and Drug Administration (FDA). The Magnetom Terra from Siemens Healthineers will be operational at Mayo Clinic later in 2017.

October 20, 2017 — Surgeons at The Johns Hopkins Hospital have for the first time used a real-time, image-guided robot ...